Related Experiment Video

Updated: Jul 16, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

How to use medicines in children: principles of paediatric clinical pharmacology

Yashwant Sinha1, Noel E Cranswick

  • 1Prince of Wales Hospital, Randwick, Victoria, Australia. yashwans@chw.edu.au

Journal of Paediatrics and Child Health
|February 24, 2007
PubMed

Insights

Pediatric drug administration knowledge lags adult data, leading to many medicines lacking child-specific dosing. This review highlights challenges in pediatric pharmacology and clinical trials, focusing on Australia.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Drug Regulation

Background:

  • Knowledge of drug administration in children and infants lags significantly behind adults.
  • Most registered medicines lack approved indications or dosing for pediatric populations.
  • Paediatric therapeutic mishaps have driven regulatory reforms, yet gaps persist.

Purpose of the Study:

  • To summarize key issues in pediatric pharmacology.
  • To discuss challenges in prescribing for children, including off-label and unlicensed use.
  • To examine the conduct of pediatric clinical trials, with a focus on Australia.

Main Methods:

  • Literature review of pediatric pharmacology and drug regulation.
  • Analysis of prescribing practices for pediatric populations.
  • Examination of regulatory frameworks and clinical trial conduct in pediatric medicine.

Main Results:

  • Significant knowledge gaps exist in pediatric drug administration.
  • Off-label and unlicensed prescribing are common in pediatric care.
  • Paediatric clinical trials face unique challenges and require specific considerations.

Conclusions:

  • Addressing knowledge deficits in pediatric pharmacology is crucial.
  • Regulatory and clinical trial improvements are needed for safe and effective pediatric drug use.
  • The situation in Australia highlights specific challenges and areas for advancement.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...